Back

Vessel normalization and maturation promotes nanoparticle delivery to solid tumors while minimizing metastases.

Izci, M.; Maksoudian, C.; Goncalves, F.; Chu, T.; Rios Luci, C.; Bolea Fernandez, E.; Vanhaecke, F.; Manshian, B. B.; Soenen, S. J.

2023-04-29 pharmacology and toxicology
10.1101/2023.04.27.538559 bioRxiv
Show abstract

Nanoparticle delivery to solid tumors is known to be an inefficient process and various studies have tried to increase efficacy, but mechanistic and comparative studies remain scarce. Here, we use pharmacological agents to study the effect of vessel normalization or vessel disintegration on nanoparticle delivery to solid tumors. Using a multiparametric approach, we find that vessel disintegration fails to improve nanoparticle delivery and instead seems to have a limiting effect. Vessel normalization, however, improves delivery efficacy for nanoparticles ranging from 20 to 60 nm diameter. The normalization of the tumor blood vessels results in reduced hypoxia, reduced necrosis and an increase in Plvap+ CD276+ endothelial cells, which have been linked with nanoparticle delivery. Interestingly, where vessel disintegration stimulated cancer cell intravasation and associated metastases, vessel normalization impeded these processes. Together, these data reveal that, vessel normalization may be a safer and more suited approach for improving nanoparticle delivery to solid tumors, but its efficacy is limited by nanoparticle diameter and tumor parameters. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=79 SRC="FIGDIR/small/538559v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@17e5e08org.highwire.dtl.DTLVardef@14f82dcorg.highwire.dtl.DTLVardef@118708eorg.highwire.dtl.DTLVardef@18593d0_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Nanobiotechnology
14 papers in training set
Top 0.1%
15.4%
2
Journal of Controlled Release
44 papers in training set
Top 0.1%
8.0%
3
Scientific Reports
3612 papers in training set
Top 10%
6.9%
4
PLOS ONE
5266 papers in training set
Top 30%
4.9%
5
Nanoscale Advances
15 papers in training set
Top 0.1%
4.4%
6
ACS Nano
113 papers in training set
Top 0.5%
4.1%
7
Biomaterials
84 papers in training set
Top 0.4%
4.1%
8
Pharmaceutics
24 papers in training set
Top 0.2%
3.3%
50% of probability mass above
9
Journal of Extracellular Biology
22 papers in training set
Top 0.1%
3.2%
10
Cancers
213 papers in training set
Top 2%
3.2%
11
Bioconjugate Chemistry
20 papers in training set
Top 0.1%
2.8%
12
Advanced Therapeutics
17 papers in training set
Top 0.1%
2.7%
13
Small
78 papers in training set
Top 0.6%
2.5%
14
Advanced Healthcare Materials
85 papers in training set
Top 0.8%
2.4%
15
Biomedicines
67 papers in training set
Top 0.7%
2.2%
16
FEBS Open Bio
31 papers in training set
Top 0.3%
1.7%
17
Molecular Pharmaceutics
16 papers in training set
Top 0.2%
1.1%
18
iScience
1154 papers in training set
Top 24%
1.1%
19
International Journal of Molecular Sciences
494 papers in training set
Top 11%
1.1%
20
ACS Omega
105 papers in training set
Top 3%
1.1%
21
Biomaterials Science
24 papers in training set
Top 0.6%
1.0%
22
Science Advances
1243 papers in training set
Top 29%
0.9%
23
Chemical Research in Toxicology
10 papers in training set
Top 0.3%
0.9%
24
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.7%
0.9%
25
Materials Today Bio
20 papers in training set
Top 0.8%
0.6%
26
Advanced Functional Materials
46 papers in training set
Top 1%
0.6%
27
Frontiers in Oncology
103 papers in training set
Top 4%
0.6%
28
Advanced Science
286 papers in training set
Top 11%
0.6%
29
Molecular Cancer Therapeutics
40 papers in training set
Top 0.9%
0.6%
30
Molecules
39 papers in training set
Top 2%
0.6%